Accelerium, S. de R.L. de C.V.

Monterrey 64000

0 studies enrolling now · 14 studies all time

What they study most

Autism, Bipolar Depression, Bronchiectasis, Crohn's Disease, Hypertension, Lupus Erythematosus, Systemic, Metastatic Renal Cell Carcinoma, Nonalcoholic Steatohepatitis, Nonalcoholic Steatohepatitis (NASH) With Fibrosis, Renal Cell Carcinoma, Schizophrenia, Systemic Lupus Erythematosus

Studies at this site

• Efficacy and Safety of Four Doses of Cenerimod Compared to Placebo in Adult Subjects With Active Systemic Lupus Erythematosus — Completed
• A Research Study to Evaluate the Efficacy and Safety of Cenerimod in Subjects Suffering From Systemic Lupus Erythematosus — Running, not enrolling
• A Study to Test Whether Different Doses of BI 1291583 Help People With Bronchiectasis — Completed
• An Efficacy and Safety Study in Children 6 to Less Than 18 Years of Age With Hypertension — Completed
• A Safety Extension Study of Ontamalimab in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA) — Completed
• A Study of Bempegaldesleukin (NKTR-214: BEMPEG) in Combination With Nivolumab Compared With the Investigator's Choice of a Tyrosine Kinase Inhibitor (TKI) Therapy (Either Sunitinib or Cabozantinib Monotherapy) for Advanced Metastatic Renal Cell Carcinoma (RCC) — Stopped early
• Phase 3 Study to Evaluate the Efficacy and Safety of Elafibranor Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH) — Stopped early
• An Efficacy and Safety Study of Ontamalimab as Maintenance Therapy in Participants With Moderate to Severe Ulcerative Colitis — Completed
• A Study Comparing the Efficacy and Safety of Etrolizumab With Adalimumab and Placebo in Participants With Moderate to Severe Ulcerative Colitis (UC) in Participants Naive to Tumor Necrosis Factor (TNF) Inhibitors — Completed
• Efficacy and Safety Study of SHP647 as Induction Therapy in Participants With Moderate to Severe Ulcerative Colitis — Stopped early
• Safety and Efficacy of Selonsertib in Adults With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH) — Stopped early
• Pediatric Open-Label Extension Study — Completed
• Efficacy and Safety of Atacicept in Systemic Lupus Erythematosus — Completed
• Pediatric Schizophrenia Efficacy and Safety Study — Completed